Clinical
RSSArticles
-
Hormonal Contraceptives Help Women Manage Perimenopause
Women near the end of their reproductive years may experience fewer perimenopausal symptoms if they use a hormonal contraceptive, such as a hormonal intrauterine device.
-
Contraceptives Dramatically Decrease Risk of Some Gynecological Cancers
Contraceptives can reduce the risk of some gynecological cancers, including protection against ovarian cancer, endometrial cancer, and uterine cancer. Women who have used oral contraceptives have a lower risk of endometrial and ovarian cancers than women who have never used the product, with a risk reduction of at least 30%.
-
Contraceptives Can Alleviate Menstrual Cramping and Endometriosis Pain
Research suggests hormonal intrauterine devices (IUDs) can relieve pelvic pain and endometriosis. One recent study revealed that levonorgestrel IUDs can improve endometriosis and ovarian function when combined with gonadotropin-releasing hormone agonists. They also can alleviate the symptoms of sexual intercourse pain and dysmenorrhea and control the risk of postoperative recurrence.
-
LARC, Pills Can Reduce or Stop Menstrual Bleeding for Extended Periods
Modern contraception offers a variety of benefits to users, in addition to effective pregnancy prevention. Perhaps the most common noncontraceptive reasons people may select some of these hormonal methods is to reduce or stop menstrual bleeding, cramping, and pain.
-
Prosocial vs. Self-Rewarding Behavior and Their Effects on Stress Recovery
Two randomized, controlled studies were created to examine the effects of giving gifts vs. receiving gifts after stressful situations. They both revealed the “giving” group reported recovering from stress faster, showing more happiness, showing less desire, and reporting no significant difference in relaxation compared to the “receiving” group and a control group.
-
The Connection Between Bereavement, Sleep, and Inflammation
This study of the association of sleep disturbance with more markers of inflammation in widows and widowers compared to controls revealed self-reported sleep disturbances are more strongly correlated with increased markers of inflammation in bereaved individuals.
-
Feds Greenlight Expanded Naloxone Availability
The FDA has approved the nasal spray version of the opioid overdose reversal agent for over-the-counter sales.
-
Bone Density as a Dementia Risk Indicator
Researchers found some associations between bone density loss and a higher risk of developing dementia.
-
Sparsentan Tablets (Filspari)
Sparsentan can be prescribed to alleviate proteinuria in adults with primary immunoglobulin A nephropathy who are at risk of rapid disease progression — generally, a urine protein-to-creatinine ratio 1.5 mg/g or higher.
-
Long-Term Maintenance Therapy After Percutaneous Coronary Intervention
An extended six-year follow-up of the HOST-EXAM study revealed the consistent benefit of the primary endpoint of fewer major cardiovascular events and less bleeding with clopidogrel vs. low-dose aspirin monotherapy in post-percutaneous coronary intervention patients who were on dual antiplatelet therapy for one year.